The Indian government has issued a notification banning Bextra (Valdecoxib) one of Pfizer’s drugs, months after the US Food & Drug Administration (USFDA) ordered its withdrawal.
The notification -- issued last week -- came after months of deliberation. An expert committee under the health ministry recommended in May that the arthritis pill Valdecoxib be banned in India. The ban will affect over 50 brands, which account for a sizeable chunk of the over-Rs 200 Cox-2 inhibitor market.
My comment: It looks like there may be a worldwide withdrawal of this drug. EU, USA, India. Who is left?
